The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-Chloro-5-methyl-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine ID: ALA266723
PubChem CID: 11724853
Max Phase: Preclinical
Molecular Formula: C19H21ClN4
Molecular Weight: 340.86
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(C2=Nc3cc(Cl)ccc3N(C)c3ccccc32)CC1
Standard InChI: InChI=1S/C19H21ClN4/c1-22-9-11-24(12-10-22)19-15-5-3-4-6-17(15)23(2)18-8-7-14(20)13-16(18)21-19/h3-8,13H,9-12H2,1-2H3
Standard InChI Key: XQIPQCHREHNRDI-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
5.5667 -6.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7542 -6.2667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0875 -5.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1667 -4.4542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2250 -5.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9042 -4.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4125 -4.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -7.0917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4292 -5.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5417 -8.7292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8042 -4.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8417 -7.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2667 -7.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8292 -5.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2625 -8.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8375 -8.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1667 -3.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9042 -5.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0167 -4.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 -5.5125 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.5292 -4.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5292 -9.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5375 -5.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3500 -4.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 6 1 0
5 2 1 0
6 3 2 0
7 5 2 0
8 1 1 0
9 5 1 0
10 15 1 0
11 7 1 0
12 8 1 0
13 8 1 0
14 9 2 0
15 13 1 0
16 12 1 0
17 4 1 0
18 3 1 0
19 14 1 0
20 14 1 0
21 6 1 0
22 10 1 0
23 18 2 0
24 23 1 0
16 10 1 0
4 7 1 0
24 21 2 0
11 19 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.86Molecular Weight (Monoisotopic): 340.1455AlogP: 3.75#Rotatable Bonds: ┄Polar Surface Area: 22.08Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.35CX LogP: 3.62CX LogD: 3.35Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.73Np Likeness Score: -0.81
References 1. de Paulis T, Betts CR, Smith HE, Mobley PL, Manier DH, Sulser F.. (1981) Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain., 24 (9): [PMID:7288815 ] [10.1021/jm00141a001 ] 2. Phillips ST, de Paulis T, Baron BM, Siegel BW, Seeman P, Van Tol HH, Guan HC, Smith HE.. (1994) Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors., 37 (17): [PMID:8064797 ] [10.1021/jm00043a008 ] 3. Smits RA, Lim HD, Stegink B, Bakker RA, de Esch IJ, Leurs R.. (2006) Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives., 49 (15): [PMID:16854056 ] [10.1021/jm051008s ]